Osteopontin (OPN) is a multi-functional protein originally discovered as a non-collagenous bone matrix protein. Considerable recent data and information deduced from mice genetically engineered null for OPN suggests that is major function may be other than a cell/matrix-matrix/cell adhesion protein. Osteopontin is produced in numerous tissues in response to injury. In numerous renal disease states, expression in renal tubular cells is stimulated. We have developed a model of renal fibrogenesis following unilateral ureteral obstruction during which OPN is rapidly up-regulated. We propose to analyze the function of OPN is renal fibrogenesis utilizing unique resources provided by several knockout mouse models. Studies will examine osteopontin is a chemotactic cytokine important in the macrophage infiltration of the renal tubular interstitium following ureteral obstruction. Further studies will analyze the role of osteopontin is a cytoprotective factor effecting the rates of renal tubular apoptosis following ureteral obstruction. Signal transduction studies will be performed utilizing a mouse model engineered null for one of the osteopontin receptors, the alphavbeta3 integrin. Additional studies will examine the function of osteopontin as a matrix protein. We will examine incorporation of osteopontin into the extracellular matrix under the influence of alphavbeta3 and tissue transglutaminase which we have also shown to be up-regulated following ureteral obstruction. Our hypothesis is that OPN is incorporated by cross- linking into macromolecular structures stabilizing the pathologic fibrotic matrix of the diseased kidney. These studies will carefully analyzed the functional role of osteopontin in this model of renal fibrogenesis and lead to the development of additional experimental strategies that may serve to ameliorate fibrogenesis and be applicable to several renal disease.

Project Start
1999-03-01
Project End
1999-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
34
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Barnes-Jewish Hospital
Department
Type
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63110
Slatopolsky, Eduardo (2011) The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder. Kidney Int Suppl :S3-8
Morrissey, Jeremiah; Guo, Guangjie; Moridaira, Kazuaki et al. (2002) Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol 13:1499-508
Morrissey, Jeremiah; Hruska, Keith; Guo, Guangjie et al. (2002) Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13 Suppl 1:S14-21
Hruska, Keith A (2002) Treatment of chronic tubulointerstitial disease: a new concept. Kidney Int 61:1911-22
Hruska, K A; Guo, G; Wozniak, M et al. (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279:F130-43
Klahr, S (1999) Mechanisms of progression of chronic renal damage. J Nephrol 12 Suppl 2:S53-62
Hemken, P; Guo, X L; Wang, Z Q et al. (1992) Immunologic evidence that vacuolar H+ ATPases with heterogeneous forms of Mr = 31,000 subunit have different membrane distributions in mammalian kidney. J Biol Chem 267:9948-57
Reyes, A A; Robertson, G; Jenden, D J et al. (1992) Subdiaphragmatic vagotomy in rats induces systemic hypertension and sodium retention. Miner Electrolyte Metab 18:375-81
Portilla, D; Mordhorst, M; Bertrand, W et al. (1988) Protein kinase C modulates phospholipase C and increases arachidonic acid release in bradykinin stimulated MDCK cells. Biochem Biophys Res Commun 153:454-62